Real-world treatment patterns before and after receiving PD-L1 test results in patients (pts) with advanced non-small cell lung cancer (aNSCLC)

被引：0
|
作者：
Antonia, S. J. [1 ]
Wu, N. [2 ]
Ge, W. [2 ]
Pouliot, J-F. [2 ]
Dietz, H. [1 ]
Jalbert, J. [2 ]
Quek, R. G. [2 ]
Harnett, J. [2 ]
机构：
[1] Duke Univ, Ctr Canc Immunotherapy, Sch Med, Durham, NC USA
[2] Regeneron Pharmaceut Inc, Tarrytown, NY USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
103P
引用
收藏
页码：S1419 / S1420
页数：2
相关论文
共 50 条
  • [1] Real-world treatment patterns before and after receiving PD-l1 test results in patients with advanced non-small cell lung cancer (aNSCLC)
    Ge, Wenzhen
    Antonia, Scott
    Wu, Ning
    Pouliot, Jean-Francois
    Dietz, Hilary
    Jalbert, Jessica
    Quek, Ruben Gw
    Harnett, James
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 111 - 112
  • [2] Real-World PD-L1 Testing Patterns for Patients with Advanced Non-Small Cell Lung Cancer in Greece
    Kokkotou, E.
    Charpidou, A.
    Papaspiliou, A.
    Stournara, L.
    Grammatikou, V.
    Ejzykowicz, F.
    Syrigos, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S660 - S660
  • [3] Comprehensive genomic profiling (CGP) and PD-L1 IHC in patients (pts) with advanced non-small cell lung cancer (aNSCLC): Testing and treatment (Tx) patterns in the real-world (RW) setting
    VanderWalde, A. M.
    Lee, J.
    Tolba, K.
    Ward, A.
    Cooper, M.
    Huang, R. S. P.
    Venstrom, J.
    Oxnard, G.
    Schrock, A. B.
    Schwartzberg, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S1006 - S1007
  • [4] Real-world treatment (tx) patterns and outcomes based on PD-L1 status in tx-naive patients (pts) with METex14 advanced non-small cell lung cancer (aNSCLC)
    Leighl, N.
    Hampe, M.
    Wu, W-H.
    Kim, J.
    Pretre, V.
    Ye, F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1059 - S1060
  • [5] Real-world treatment sequencing in advanced non-small cell lung cancer (aNSCLC).
    Radtchenko, Janna
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Real-world data analysis of PD-L1 expression and overall survival (OS) in advanced non-small cell lung cancer (aNSCLC)
    Staib, J.
    Sudarsanam, S.
    Byfield, S. Dacosta
    Kennedy, C.
    Weiss, L.
    ANNALS OF ONCOLOGY, 2019, 30 : 27 - 27
  • [7] Real-world survival with first-line (1L) chemotherapy in patients (pts) with advanced non-small cell lung cancer (aNSCLC)
    Waterhouse, D.
    Betts, K. A.
    Zhao, J.
    Rao, S.
    Gupte-Singh, K.
    Rutstein, M.
    Higashi, M. K.
    Schwartzberg, L.
    ANNALS OF ONCOLOGY, 2019, 30 : 29 - U99
  • [8] Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer.
    Leapman, Michael
    Presley, Carolyn J.
    Zhu, Weiwei
    Soulos, Pamela R.
    Adelson, Kerin B.
    Boffa, Daniel J.
    Gross, Cary Philip
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Treatment patterns in patients with advanced non-small cell lung cancer (aNSCLC): real-world data from the United Kingdom
    Lester, J.
    Khan, S.
    Powell, C.
    Escriu, C.
    Hudson, E.
    Conn, A.
    Mansy, T.
    Chan, S.
    Brock, J.
    Zhuo, X.
    Durand, A.
    Zhang, X.
    Pawar, V.
    LUNG CANCER, 2020, 139 : S47 - S48
  • [10] PD-L1 Testing Patterns and Treatment in Patients With Metastatic Non-Small Cell Lung Cancer in Israel - Analysis of Real-World Data
    Apter, L.
    Moser, S. Sharman
    Arunachalam, A.
    Burke, T.
    Shalev, V.
    Chodick, G.
    Siegelmann-Danieli, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S307 - S308
12345